Evidence map›Paper›PMID 37758507›Full record

Trial reportThe British journal of surgery2023

Impact of autofluorescence for detection of parathyroid glands during thyroidectomy on postoperative parathyroid hormone levels: parallel multicentre randomized clinical trial.

Anders Bergenfelz, Marcin Barczynski, Anette Heie, Andreas Muth, Christian Passler, Max Schneider, Paulina Wierzbicka, Alexander Konturek, Katrin Brauckhoff, Anna-Karin Elf and 2 more

2 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in The British journal of surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04509011 nacompletednot on this map

Randomized Controlled Trial of Fluobeam® LX Compared With Clinical Assessment of Parathyroid Glands to Counteract Postoperatively Failing Parathyroid Function With Low Blood Calcium After Thyroid Surgery

TypeinterventionalSponsorRegion SkaneRan2021 to 2023Enrolled516ConditionsHypoparathyroidism PostproceduralArmsFluobeam® LX
NCT06765941 narecruitingnot on this mapstarted 2025, after this paper: background citation

Clinical Validation of Probe-based Parathyroid Autofluorescence Detection System PTeye vs Surgeons Eyes in Intraoperative Identification and Functional Preservation of Parathyroid Glands During Thyroid Surgery: A Parallel Randomized Controlled Clinical Trial.

TypeinterventionalSponsorMarcin BarczynskiRan2025 to 2026Enrolled154ConditionsThyroid Surgery, Parathyroid Dysfunction, Hypoparathyroidism Post-surgicalArmsProbe-based near-infrared parathyroid autofluorescence detection system, Surgeons naked eyes for parathyroid glands identification
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Fluorescent Imaging in Thyroid Surgery to Preserve Parathyroid Function: A Systematic Review and Meta-Analysis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Inadvertent parathyroidectomy in thyroid surgery with and without near-infrared autofluorescence: a two-centre retrospective observational study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. [Endocrine oncology : An update on surgical treatments].Innere Medizin (Heidelberg, Germany) · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Anders BergenfelzDepartment of Clinical Sciences-Lund, Medical Faculty, Lund University, Lund, Sweden.ORCID 0000-0002-8355-6025
Marcin BarczynskiDepartment of Endocrine Surgery, Jagiellonian University Medical College, Krakow, Poland.ORCID 0000-0001-6062-1851
Anette HeieDepartment of Breast and Endocrine Surgery, Haukeland University Hospital, Bergen, Norway.
Andreas MuthDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID 0000-0003-0857-1521
Christian PasslerDepartment of Surgery, Klinik Landstraße, Wiener Gesundheitsverbund, Vienna, Austria.
Max SchneiderDepartment of Surgery, Klinik Landstraße, Wiener Gesundheitsverbund, Vienna, Austria.
Paulina WierzbickaDepartment of Endocrine Surgery, Jagiellonian University Medical College, Krakow, Poland.
Alexander KonturekDepartment of Endocrine Surgery, Jagiellonian University Medical College, Krakow, Poland.
Katrin BrauckhoffDepartment of Breast and Endocrine Surgery, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0002-2442-3281
Anna-Karin ElfDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Jakob DahlbergDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Michael HermannDepartment of Surgery, Klinik Landstraße, Wiener Gesundheitsverbund, Vienna, Austria.
Jagiellonian University · PLSahlgrenska University Hospital · SEWiener Krankenanstaltenverbund · ATHaukeland University Hospital · NOLund University · SE

Funding

Region Skåne
6 · The paper itself

Abstract

backgroundTechniques for autofluorescence have been introduced to visualize the parathyroid glands during surgery and to reduce hypoparathyroidism after thyroidectomy.

methodsThis parallel multicentre RCT investigated the use of Fluobeam® LX to visualize the parathyroid glands by autofluorescence during total thyroidectomy compared with no use. There was no restriction on the indication for surgery. Patients were randomized 1 : 1 and were blinded to the group allocation. The hypothesis was that autofluorescence enables identification and protection of the parathyroid glands during thyroidectomy. The primary endpoint was the rate of low parathyroid hormone (PTH) levels the day after surgery.

resultsSome 535 patients were randomized, and 486 patients received an intervention according to the study protocol, 246 in the Fluobeam® LX group and 240 in the control group. Some 64 patients (26.0 per cent) in the Fluobeam® LX group and 77 (32.1 per cent) in the control group had low levels of PTH after thyroidectomy (P = 0.141; relative risk (RR) 0.81, 95 per cent c.i. 0.61 to 1.07). Subanalysis of 174 patients undergoing central lymph node clearance showed that 15 of 82 (18 per cent) in the Fluobeam® LX group and 31 of 92 (33 per cent) in the control group had low levels of PTH on postoperative day 1 (P = 0.021; RR 0.54, 0.31 to 0.93). More parathyroid glands were identified during operation in patients who had surgery with Fluobeam® LX, and fewer parathyroid glands in the surgical specimen on definitive histopathology. No specific harm related to the use of Fluobeam® LX was reported.

conclusionThe use of autofluorescence during thyroidectomy did not reduce the rate of low PTH levels on postoperative day 1 in the whole group of patients. It did, however, reduce the rate in a subgroup of patients. Registration number: NCT04509011 (http://www.clinicaltrials.gov).

Indexed as

HypocalcemiaHypoparathyroidismHumansLymph NodesParathyroid GlandsParathyroid HormonePostoperative ComplicationsThyroidectomyParathyroid Hormone

Identifiers

PMID37758507
PMCPMC10638529
OpenAlexW4387078526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.